References
Rossi JG, Bernasconi AR, Alonso CN, Rubio PL, Gallego MS, Carrara CA, Guitter MR, Eberle SE, Cocce M, Zubizarreta PA, Felice MS (2012) Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol 87(9):890–897. doi:10.1002/ajh.23266
Dorantes-Acosta E, Pelayo R (2012) Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone marrow research 2012:406796. doi:10.1155/2012/406796
Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, McLeod JL, Doedens M, Medeiros JJ, Marke R, Kim HJ, Lee K, McPherson JD, Hudson TJ, Brown AM, Yousif F, Trinh QM, Stein LD, Minden MD, Wang JC, Dick JE (2014) Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506(7488):328–333. doi:10.1038/nature13038
van der Velden VH, van Lom K, Hoogeveen PG, Beverloo HB, Breems DA (2006) Unusual immunophenotypic shift in a patient with T-cell acute lymphoblastic leukemia. Leukemia 20(9):1626–1629. doi:10.1038/sj.leu.2404297
Paganin M, Buldini B, Germano G, Seganfreddo E, Meglio A, Magrin E, Grillo F, Pigazzi M, Rizzari C, Cazzaniga G, Khiabanian H, Palomero T, Rabadan R, Ferrando AA, Basso G (2016) A case of T-cell acute lymphoblastic leukemia relapsed as myeloid acute leukemia. Pediatr Blood Cancer 63(9):1660–1663. doi:10.1002/pbc.26054
van den Ancker W, Terwijn M, Regelink J, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA, Zweegman S (2009) Uncommon lineage switch warrants immunophenotyping even in relapsing leukemia. Leuk Res 33(7):e77–e80. doi:10.1016/j.leukres.2008.11.029
Gagnon GA, Childs CC, LeMaistre A, Keating M, Cork A, Trujillo JM, Nellis K, Freireich E, Stass SA (1989) Molecular heterogeneity in acute leukemia lineage switch. Blood 74(6):2088–2095
Hershfield MS, Kurtzberg J, Harden E, Moore JO, Whang-Peng J, Haynes BF (1984) Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2′-deoxycoformycin. Proceedings of the National Academy of Sciences of the United States of America 81 (1):253–257
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from the patient.
Rights and permissions
About this article
Cite this article
Matern, S., Schmidt, E., Hartmann, D. et al. Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcoma. Ann Hematol 96, 1201–1203 (2017). https://doi.org/10.1007/s00277-017-3000-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-017-3000-3